✦ LIBER ✦

The treatment of Wilms' tumor: Results from Royal Children's Hospital, Melbourne, 1967–1977

✍ Scribed by John M. Hutson; M. Kent; H. Ekert; Keith D. Waters

Book ID: 117155875
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 362 KB
Volume: 18
Category: Article
ISSN: 0022-3468
DOI: 10.1016/s0022-3468(83)80091-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term endocrine effects of cancer tr

Long-term endocrine effects of cancer treatment: Experience of the Royal Children's Hospital, Melbourne

✍ R Hameed; MR Zacharin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Audit of Referrals for Labial Appearance

Audit of Referrals for Labial Appearance Concerns at the Royal Children's Hospital Melbourne: From 2000 Onwards

✍ McQuillan, Dr. Sarah K.; Jayasinghe, Dr. Yasmin L.; Grover, Dr. Sonia R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 202 KB

The clinical significance of anismus in

The clinical significance of anismus in treatment-resistant encopresis: A.G. Catto-Smith, ∗T.M. Nolan, ∗C.M.M. Coffey. Department of Gastroenterology, Royal Children's Hospital and Department of Paediatrics, University of Melbourne, Melbourne, Australia

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 139 KB

A Survey of the Results of the Treatment

A Survey of the Results of the Treatment of Prolapse and Retroversion in the Royal Free Hospital from 1926 to 1933

✍ Margaret Salmond; Gertrude Dearnley 📂 Article 📅 1935 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB

Comparison of outcomes based on treatmen

Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: Combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee

✍ David A. Rodeberg; James R. Anderson; Carola A. Arndt; Fernando A. Ferrer; Richa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 325 KB

## Abstract The purpose of this study was to determine patient characteristics and outcomes for bladder/prostate (BP) rhabdomyosarcoma (RMS) using an international cohort of prospectively treated patients comparing different treatment algorithms. Data were collected from 379 patients (1979–1998) tr

40 kDa peginterferon alfa-2A (PEGASYS®):

40 kDa peginterferon alfa-2A (PEGASYS®): efficacy and safety results from a phase II, randomized, actively controlled, multicenter study in the treatment of HBeAg positive chronic hepatitis B: Graham E Cooksley, Royal Brisbane Hospital, Herston, Queensland Australia; Teerha Piratvisuth, Songklanakarin Hospital, Songkla Thailand; Yuan-Jen Wang, Teipei Veterans General Hospital, Taipei Taiwan; Varocha Mahachai, Chulalongkorn Hospital, Bangkok Thailand; You-Chen Chao, Tri Service General Hosptital, Taipei Taiwan; Tawesak Tanwandee, Siriraj Hospital, Bangkok Thailand; Anuchit Chutaputti, Pramongkutklao Hospital, Bangkok Thailand; Wen Yu Chang, Kaohsiung University Hospital, Kaohsiung Taiwan; Friederike E Zahm, Hoffmann-La Roche Basel Switzerland; Nigel Pluck, Roche Products Ltd, Welwyn Uk

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB